It was demonstrated that NUCB2/NESF1 intensified proliferation, invasion, and migration processes in colon, breast, endometrial, papillary thyroid, bladder, and renal cancer cells [19,21,22,23,24,25]. Here, NUCB2 is linked to renal carcinoma.